Data_Sheet_1_Detecting lncRNA–Cancer Associations by Combining miRNAs, Genes, and Prognosis With Matrix Factorization.docx

Motivation: Long non-coding RNAs (lncRNAs) play important roles in cancer development. Prediction of lncRNA–cancer association is necessary for efficiently discovering biomarkers and designing treatment for cancers. Currently, several methods have been developed to predict lncRNA–cancer associations. However, most of them do not consider the relationships between lncRNA with other molecules and with cancer prognosis, which has limited the accuracy of the prediction.
Method: Here, we constructed relationship matrices between 1,679 lncRNAs, 2,759 miRNAs, and 16,410 genes and cancer prognosis on three types of cancers (breast, lung, and colorectal cancers) to predict lncRNA–cancer associations. The matrices were iteratively reconstructed by matrix factorization to optimize low-rank size. This method is called detecting lncRNA cancer association (DRACA).
Results: Application of this method in the prediction of lncRNAs–breast cancer, lncRNA–lung cancer, and lncRNA–colorectal cancer associations achieved an area under curve (AUC) of 0.810, 0.796, and 0.795, respectively, by 10-fold cross-validations. The performances of DRACA in predicting associations between lncRNAs with three kinds of cancers were at least 6.6, 7.2, and 6.9% better than other methods, respectively. To our knowledge, this is the first method employing cancer prognosis in the prediction of lncRNA–cancer associations. When removing the relationships between cancer prognosis and genes, the AUCs were decreased 7.2, 0.6, and 5% for breast, lung, and colorectal cancers, respectively. Moreover, the predicted lncRNAs were found with greater numbers of somatic mutations than the lncRNAs not predicted as cancer-associated for three types of cancers. DRACA predicted many novel lncRNAs, whose expressions were found to be related to survival rates of patients. The method is available at https://github.com/Yanh35/DRACA.